Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Pediatr ; 160(5): 796-800.e1, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22133423

RESUMO

OBJECTIVE: To describe the incidence and predictors of total serum bilirubin (TSB) levels that meet or exceed American Academy of Pediatrics (AAP) exchange transfusion (ET) thresholds in the setting of universal screening. STUDY DESIGN: We conducted a retrospective cohort analysis of electronic data on 18 089 newborns ≥35 weeks gestation born at Northern California Kaiser Permanente Medical Care Program hospitals implementing universal TSB screening in 2005 to 2007, with chart review for subjects with TSB levels reaching the AAP threshold for ET. RESULTS: The outcome developed in 22 infants (0.12%); 14 (63.6%) were <38 weeks gestation. Only one infant received an ET; none of the infants had documented sequelae. The first TSB was at least high-intermediate risk on the AAP risk-nomogram for all 22 infants and high-risk for those ≥38 weeks, but was less than the phototherapy level in 15 infants (68%). Of these 15 infants, 2 failed phototherapy and 13 did not have a TSB repeated in <24 hours. However, re-testing all infants at high-intermediate risk or greater would have required 2166 additional bilirubin tests. CONCLUSION: Screening was sensitive but not specific for predicting exchange threshold.


Assuntos
Bilirrubina/sangue , Transfusão Total/normas , Recém-Nascido Prematuro , Icterícia Neonatal/terapia , Triagem Neonatal/normas , California , Estudos de Coortes , Bases de Dados Factuais , Transfusão Total/tendências , Feminino , Seguimentos , Guias como Assunto , Humanos , Recém-Nascido , Icterícia Neonatal/sangue , Icterícia Neonatal/diagnóstico , Masculino , Valor Preditivo dos Testes , Padrões de Referência , Estudos Retrospectivos , Medição de Risco , Resultado do Tratamento
2.
Bol Asoc Med P R ; 102(1): 13-7, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20853567

RESUMO

BACKGROUND: Sickle cell disease (SCD) patients suffer complications requiring simple and/or exchange transfusion. In 1999 we developed an automated exchange technique using infusion pumps and vascular catheters (IV Pump Method). OBJECTIVE: To prove that IV Pump Method is cost-efficient, and as safe and effective as automated cell separators. METHODS: Retrospective chart review of SCD patients requiring exchange transfusion admitted to PICU from 2003-2009. Evaluated method used, complications, costs, and Hemoglobin S% (HgS%) change, excluding patients not requiring exchange transfusion. RESULTS: Cost-reduction with IV Pump Method is around $1000. Average HgS% reduction using IV Pump Method was 30.3 vs. 28.8 in Blood Cell Separator group (p = 0.84). We had no complications or mortalities, with the majority of patients being male (p = 0.03) and on the oldest age group (11-19 y/o) for both methods. CONCLUSION: The IV Pump Method is a safe, effective, and cost-efficient alternative to perform exchange transfusion.


Assuntos
Anemia Falciforme/terapia , Transfusão Total/economia , Transfusão Total/normas , Adolescente , Criança , Pré-Escolar , Análise Custo-Benefício , Feminino , Humanos , Masculino , Estudos Retrospectivos , Segurança
3.
J Pediatr Surg ; 28(2): 144-50, 1993 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8437066

RESUMO

The present study was designed to evaluate the effect of a perfluorocarbon erythrocyte substitute on hemodynamics in the newborn lamb. Isovolumic double volume exchange transfusions were performed with perfluorocarbon emulsion (FC-43) on lambs who were ventilated to maintain normal acid base status. Hematocrit, fluorocrit, viscosity, arterial gas tensions, mean arterial pressure, and heart rate were determined before (control) and after (exchange) exchange transfusion. A radiolabeled microsphere technique was used and cardiac output, organ blood flow, organ vascular resistance, and oxygen delivery were calculated. As the hematocrit and viscosity decreased and the fluorocrit increased, there was a significant increase in PaO2 as well as a significant decrease in A-a gradient and oxygen content. There was no significant change in the acid-base status or the hemodynamic profile (heart rate, stroke volume, cardiac output, and mean arterial pressure). Blood flow to the heart and brain showed a significant increase, whereas flow to the cortex of the kidney showed a significant decrease. There was no significant change in flow to the gastrointestinal tract. Organ vascular resistance in the brain significantly decreased, increased in the kidney, and showed no significant change in the heart and gastrointestinal tract. Oxygen delivery significantly decreased in all organs except the heart. These data suggest that perfluorocarbon emulsions can acutely maintain hemodynamic stability in the newborn lamb and that the intrinsic properties of perfluorocarbons allow for the preservation of adequate oxygenation and acid-base status.


Assuntos
Animais Recém-Nascidos/fisiologia , Transfusão Total/normas , Fluorocarbonos/uso terapêutico , Hemodinâmica/efeitos dos fármacos , Vísceras/efeitos dos fármacos , Animais , Gasometria , Viscosidade Sanguínea/efeitos dos fármacos , Radioisótopos de Carbono , Avaliação Pré-Clínica de Medicamentos , Transfusão Total/métodos , Fluorocarbonos/administração & dosagem , Fluorocarbonos/farmacologia , Hematócrito , Humanos , Microesferas , Consumo de Oxigênio/efeitos dos fármacos , Ovinos , Vísceras/irrigação sanguínea
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA